October 2017

Pictured from left to right: Sharon M. Joyce, Acting Director, Division of Consumer Affairs; Christopher S. Porrino, Attorney…

As opposition to and concern about the activities of drug manufacturers continue to mount, increasingly states, and even cities,…

As physician practices consider joining an alternative payment model (APM), Medical Economics published an interesting list of…

The concern of misbranded products leading to patient harm and potential fraud is inarguable. The FDA has held a long-standing…

The FDA recently released draft guidance offering recommendations for holders of biologics license applications (BLAs) on the…

A coalition of 41 states' attorneys general have served five major opioid manufacturers with subpoenas seeking information about…

On September 27, 2017, AmerisourceBergen Specialty Group (ABSG), a wholly-owned subsidiary of AmerisourceBergen Corporation, one…

At the end of September, Florida Governor Rick Scott announced that during the upcoming legislative session, he will propose new…

The American Board of Medical Specialties (ABMS) and its twenty-four Member Boards have launched a major initiative, "Continuing…

The American Medical Association (AMA) and the ACCME are working together to develop a list of frequently asked questions (FAQ),…